These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 7498987)
1. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Paula RD; Lima CV; Khosla MC; Santos RA Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I. Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Paula RD; Lima CV; Britto RR; Campagnole-Santos MJ; Khosla MC; Santos RA Peptides; 1999; 20(4):493-500. PubMed ID: 10458520 [TBL] [Abstract][Full Text] [Related]
5. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats. Carvalho MB; Duarte FV; Faria-Silva R; Fauler B; da Mata Machado LT; de Paula RD; Campagnole-Santos MJ; Santos RA Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Oliveira MA; Fortes ZB; Santos RA; Kosla MC; De Carvalho MH Peptides; 1999; 20(10):1195-201. PubMed ID: 10573291 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Li P; Chappell MC; Ferrario CM; Brosnihan KB Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Iyer SN; Ferrario CM; Chappell MC Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Almeida AP; Frábregas BC; Madureira MM; Santos RJ; Campagnole-Santos MJ; Santos RA Braz J Med Biol Res; 2000 Jun; 33(6):709-13. PubMed ID: 10829099 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Abbas A; Gorelik G; Carbini LA; Scicli AG Hypertension; 1997 Aug; 30(2 Pt 1):217-21. PubMed ID: 9260983 [TBL] [Abstract][Full Text] [Related]
14. Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits. Whorlow SL; Angus JA; Wright CE J Cardiovasc Pharmacol; 1998 Dec; 32(6):951-61. PubMed ID: 9869501 [TBL] [Abstract][Full Text] [Related]
15. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668 [TBL] [Abstract][Full Text] [Related]
16. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432 [TBL] [Abstract][Full Text] [Related]
17. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Stanziola L; Greene LJ; Santos RA Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789 [TBL] [Abstract][Full Text] [Related]
18. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]